Early Prediction of Long-Term Response to Cabergoline in Patients with Macroprolactinomas
Youngki Lee (Lee Y), Cheol Ryong Ku (Ku CR), Eui-Hyun Kim (Kim EH), Jae Won Hong (Hong JW), Eun Jig Lee (Lee EJ), Sun Ho Kim (Kim SH)
Endocrinol Metab. 2014;29(3):280-292.   Published online 2014 Sep 25     DOI: https://doi.org/10.3803/EnM.2014.29.3.280
Citations to this article as recorded by Crossref logo
Biochemical Remission after Cabergoline Withdrawal in Hyperprolactinemic Patients with Visible Remnant Pituitary Adenoma
Kyungwon Kim, Yae Won Park, Daham Kim, Sung Soo Ahn, Ju Hyung Moon, Eui Hyun Kim, Eun Jig Lee, Cheol Ryong Ku
The Journal of Clinical Endocrinology & Metabolism.2021; 106(2): e615.     CrossRef
Predictors of dopamine agonist resistance in prolactinoma patients
Elle Vermeulen, Jean D’Haens, Tadeusz Stadnik, David Unuane, Kurt Barbe, Vera Van Velthoven, Sven Gläsker
BMC Endocrine Disorders.2020;[Epub]     CrossRef
The Role of Dopamine Agonists in Pituitary Adenomas
Erica A. Giraldi, Adriana G. Ioachimescu
Endocrinology and Metabolism Clinics of North America.2020; 49(3): 453.     CrossRef
Prevalence of Thyroid Disease in Patients Surgically Treated for Pituitary Disease
Kim, Cho, Ku, Jung, Moon, Kim, Shin, Kim, Lee
Journal of Clinical Medicine.2019; 8(8): 1142.     CrossRef
Articles in 'Endocrinology and Metabolism' in 2014
Won-Young Lee
Endocrinology and Metabolism.2015; 30(1): 47.     CrossRef